Scientists discover new brain role of common diabetes drug

A widely used diabetes drug taken for over six decades may be working in ways scientists did not fully understand until now, with new research suggesting it directly affects the brain.

This finding is significant as it alters experts’ perception of the drug’s role in blood sugar control and paves the way for future treatments aimed at the brain.

What the study found

The drug, metformin, has long been prescribed to manage type 2 diabetes by lowering blood glucose levels. Traditionally, it was believed to work mainly through the liver and gut.

But according to a recent study, the medication also affects a particular area of the brain that controls metabolism. Researchers identified a pathway in the brain where the drug appears to influence glucose control.

Tests on mice indicated that metformin reaches a region called the ventromedial hypothalamus and works by switching off a protein linked to glucose regulation.

Why this discovery matters

This new understanding could lead to more targeted treatments for diabetes by focusing on how the brain controls metabolism.

Scientists say the findings may help develop drugs that act more precisely on these brain pathways, potentially improving treatment outcomes in the future.

The research also adds to earlier studies suggesting that metformin may have broader health benefits, including possible effects on brain ageing and longevity.

More than just a diabetes drug

Metformin is considered one of the most widely used and affordable treatments for type 2 diabetes. It works by reducing glucose production in the liver and improving how the body uses insulin.

The new findings suggest its impact is more complex, involving the brain alongside other organs.

Researchers also noted that the brain responds to lower levels of the drug compared to other parts of the body, highlighting its potential importance in treatment mechanisms.

What happens next

Scientists caution that further studies in humans are necessary to confirm these findings, despite the promising results.

If validated, this discovery has the potential to reshape diabetes treatment and may even lead to new therapies targeting neurological and metabolic conditions.

The study offers a fresh perspective on a decades-old drug, showing that even well-established treatments can still reveal new mechanisms. Understanding how metformin works in the brain could play a key role in improving future diabetes care.